{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:13:47Z","timestamp":1789517627968,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["111S131"],"award-info":[{"award-number":["111S131"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bcp.2022.115317","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T21:17:17Z","timestamp":1667078237000},"page":"115317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The Ca2+\/CaM, Src kinase and\/or PI3K-dependent EGFR transactivation via 5-HT2A and 5-HT1B receptor subtypes mediates 5-HT-induced vasoconstriction"],"prefix":"10.1016","volume":"206","author":[{"given":"Sahika","family":"Guner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamila","family":"Akhayeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Gurdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2022.115317_b0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1152\/physrev.2001.81.3.999","article-title":"Vascular smooth muscle growth: autocrine growth mechanisms","volume":"81","author":"Berk","year":"2001","journal-title":"Physiol. Rev."},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2022.115317_b0010","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/00005344-198706103-00004","article-title":"Cardiovascular effects of serotonin","volume":"10","author":"Vanhoutte","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115317_b0015","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.amjhyper.2004.08.019","article-title":"Vascular stiffening and arterial compliance: implications for systolic blood pressure","volume":"17","author":"Schiffrin","year":"2004","journal-title":"Am. J. Hypertens."},{"issue":"2","key":"10.1016\/j.bcp.2022.115317_b0020","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1124\/pr.115.010652","article-title":"Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders","volume":"68","author":"Brozovich","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2022.115317_b0025","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/pr.111.004697","article-title":"Serotonin and blood pressure regulation","volume":"64","author":"Watts","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bcp.2022.115317_b0030","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/bjp.2008.111","article-title":"The existence of a local 5-hydroxytryptaminergic system in peripheral arteries","volume":"154","author":"Ni","year":"2008","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl 3","key":"10.1016\/j.bcp.2022.115317_b0035","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1097\/00005344-198706103-00005","article-title":"Serotonin agonists and antagonists in experimental hypertension","volume":"10","author":"Saxena","year":"1987","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115317_b0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1073\/pnas.83.3.674","article-title":"Stimulation of aortic smooth muscle cell mitogenesis by serotonin","volume":"83","author":"Nemecek","year":"1986","journal-title":"PNAS"},{"key":"10.1016\/j.bcp.2022.115317_b0045","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0022-3565(24)35225-5","article-title":"Mechanisms of 5-hydroxytryptamine (2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth","volume":"291","author":"Banes","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"10.1016\/j.bcp.2022.115317_b0050","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.pharmthera.2005.12.004","article-title":"5-Hydroxytryptamine receptors in the human cardiovascular system","volume":"111","author":"Kaumann","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2022.115317_b0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(24)29514-8","article-title":"Characterization of the serotonin receptor mediating contraction in the mouse thoracic aorta and signal pathway coupling","volume":"297","author":"McKune","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2022.115317_b0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.bjp.0704709","article-title":"Involvement of 5-HT1B and 5-HT1D receptors in sumatriptan mediated vasocontractile response in rabbit common carotid artery","volume":"136","author":"Ak\u0131n","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115317_b0065","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0022-3565(25)23449-8","article-title":"Phasic and tonic components in 5-HT2 receptor-mediated rat aorta contraction: Participation of Ca2+ channels and phospholipase C","volume":"234","author":"Nakaki","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.bcp.2022.115317_b0070","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0028-3908(84)90244-2","article-title":"Aortic recognition sites for serotonin (5HT) are coupled to phospholipase C and modulate phosphatidylinositol turnover","volume":"23","author":"Roth","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2022.115317_b0075","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1113\/jphysiol.2008.153593","article-title":"c-Src tyrosine kinase, a critical component for 5-HT2A receptor-mediated contraction in rat aorta","volume":"586","author":"Lu","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2022.115317_b0080","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/jpet.103.062265","article-title":"Rho\/Rho Kinase and Phosphoinositide 3-Kinase Are Parallel Pathways in the Development of Spontaneous Arterial Tone in Deoxycorticosterone Acetate-Salt Hypertension","volume":"309","author":"Wehrwein","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"14","key":"10.1016\/j.bcp.2022.115317_b0085","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1016\/S0021-9258(19)38983-5","article-title":"Epidermal growth factor","volume":"265","author":"Carpenter","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115317_b0090","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2005.06.038","article-title":"The epidermal growth factor receptors and their family of ligands: Their putative role in atherogenesis","volume":"186","author":"Dreux","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bcp.2022.115317_b0095","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1161\/ATVBAHA.111.223537","article-title":"Consequences of epidermal growth factor receptor (ErbB1) loss for vascular smooth muscle cells from mice with targeted deletion of ErbB1","volume":"31","author":"Schreier","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcp.2022.115317_b0100","doi-asserted-by":"crossref","first-page":"8890","DOI":"10.1074\/jbc.273.15.8890","article-title":"Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells","volume":"273","author":"Eguchi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115317_b0105","doi-asserted-by":"crossref","first-page":"27335","DOI":"10.1074\/jbc.M103578200","article-title":"G protein-coupled receptors desensitize and down-regulate epidermal growth factor receptors in renal mesangial cells","volume":"276","author":"Grewal","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115317_b0110","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1476-5381.2010.00829.x","article-title":"\u03b11-Adrenoceptor-mediated contraction of rat aorta is partly mediated via transactivation of the epidermal growth factor receptor","volume":"61","author":"Ulu","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115317_b0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1124\/jpet.113.206243","volume":"347","author":"Ulu","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2022.115317_b0120","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI111772","article-title":"Epidermal growth factor, a vascular smooth muscle mitogen, induces rat aortic contraction","volume":"75","author":"Berk","year":"1985","journal-title":"J Clin Invest."},{"issue":"3","key":"10.1016\/j.bcp.2022.115317_b0125","doi-asserted-by":"crossref","first-page":"R878","DOI":"10.1152\/ajpregu.2001.281.3.R878","article-title":"Mineralocorticoids up-regulate arterial contraction to epidermal growth factor","volume":"281","author":"Florian","year":"2001","journal-title":"Am. J. Physiol. Regulatory Integrative Comp Physiol."},{"key":"10.1016\/j.bcp.2022.115317_b0130","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1146\/annurev-pharmtox-070115-095427","article-title":"Epidermal Growth Factor Receptor Transactivation: Mechanisms, Pathophysiology, and Potential Therapies in the Cardiovascular System","volume":"56","author":"Forrester","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.bcp.2022.115317_b0135","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2337\/db07-0739","article-title":"Elevated epidermal growth factor receptor phosphorylation induces resistance artery dysfunction in diabetic db\/db mice","volume":"57","author":"Belmadani","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2022.115317_b0140","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/HYPERTENSIONAHA.115.05344","article-title":"Role of epidermal growth factor receptor and endoplasmic reticulum stress in vascular remodeling induced by angiotensin II","volume":"65","author":"Takayanagi","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2022.115317_b0145","first-page":"4591","article-title":"Inhibition of epidermal growth factor receptor attenuates atherosclerosis via decreasing inflammation and oxidative stress","volume":"8","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2022.115317_b0150","doi-asserted-by":"crossref","first-page":"E1790","DOI":"10.1152\/ajpendo.00708.2006","article-title":"Aldosterone- induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter","volume":"292","author":"Grossmann","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.bcp.2022.115317_b0155","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1097\/01.ASN.0000098681.56240.1A","article-title":"Importance of functional EGF receptors in recovery from acute nephrotoxic injury","volume":"14","author":"Wang","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.bcp.2022.115317_b0160","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1172\/JCI31901","article-title":"\u03b2-arrestin\u2013mediated \u03b21-adrenergic receptor transactivation of the EGFR confers cardioprotection","volume":"117","author":"Noma","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bcp.2022.115317_b0165","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/01.HYP.0000047104.42047.9B","article-title":"Antisense to epidermal growth factor receptor prevents the development of left ventricular hypertrophy","volume":"41","author":"Kagiyama","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2022.115317_b0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/jpet.113.203497","article-title":"Epidermal growth factor receptor inhibitor PKI-166 governs cardiovascular protection without beneficial effects on the kidney in hypertensive 5\/6 nephrectomized rats","volume":"345","author":"Ulu","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"10.1016\/j.bcp.2022.115317_b0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/cvr\/cvq030","article-title":"GPCR agonist-induced transactivation of the EGFR upregulates MLC II expression and promotes hypertension in insulin-resistant rats","volume":"87","author":"Nagareddy","year":"2010","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2022.115317_b0180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/01.HYP.38.1.56","article-title":"Src is an important mediator of extracellular signal-regulated kinase 1\/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients","volume":"38","author":"Touyz","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2022.115317_b0185","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/HYPERTENSIONAHA.116.07699","article-title":"c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II-Induced Hypertension","volume":"68","author":"Callera","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.bcp.2022.115317_b0190","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1742-4658.2009.07469.x","article-title":"Calmodulin-mediated regulation of the epidermal growth factor receptor","volume":"277","author":"Sanchez-Gonzalez","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.bcp.2022.115317_b0195","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1126\/science.7892601","article-title":"Tyrosine kinase inhibition: an approach to drug development","volume":"267","author":"Levitzki","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bcp.2022.115317_b0200","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1111\/bph.15811","article-title":"Community guidelines for GPCR ligand bias: IUPHAR review 32","volume":"179","author":"Kolb","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115317_b0205","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/cvr\/cvn325","article-title":"Phosphoinositide 3-kinase signalling in the vascular system","volume":"82","author":"Morello","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.bcp.2022.115317_b0210","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1038\/emm.2013.116","article-title":"Serotonin contracts the rat mesenteric artery by inhibiting 4-aminopyridine-sensitive Kv channels via the 5-HT2A receptor and Src tyrosine kinase","volume":"45","author":"Sung","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bcp.2022.115317_b0215","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12421","article-title":"KV channels and the regulation of vascular smooth muscle tone","volume":"25","author":"Jackson","year":"2018","journal-title":"Microcirculation"},{"key":"10.1016\/j.bcp.2022.115317_b0220","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.apha.2016.07.001","article-title":"Potassium Channels in Regulation of Vascular Smooth Muscle Contraction and Growth","volume":"78","author":"Jackson","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bcp.2022.115317_b0225","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1046\/j.1471-4159.2003.01921.x","article-title":"A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases","volume":"86","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2022.115317_b0230","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00004872-200103000-00012","article-title":"Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells","volume":"19","author":"Touyz","year":"2001","journal-title":"J. Hypertens."},{"key":"10.1016\/j.bcp.2022.115317_b0235","doi-asserted-by":"crossref","first-page":"19443","DOI":"10.1074\/jbc.271.32.19443","article-title":"Role of c-Src tyrosine kinase in G protein-coupled receptor- and G betagamma subunit-mediated activation of mitogen-activated protein kinases","volume":"271","author":"Luttrell","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2022.115317_b0240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0092-8674(00)00086-6","article-title":"Src tyrosine kinase is a novel direct effector of G proteins","volume":"102","author":"Ma","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2022.115317_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134524","article-title":"Inverse agonists of the 5-HT2A receptor reduce nicotine withdrawal signs in rats","volume":"713","author":"Malin","year":"2019","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2022.115317_b0250","doi-asserted-by":"crossref","unstructured":"B.E. Hawes, L.M. Luttrell, T. van Biesen, R.J. Lefkowitz, Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway, J. Biol. Chem., 271 (1996) 12133-36.","DOI":"10.1074\/jbc.271.21.12133"},{"key":"10.1016\/j.bcp.2022.115317_b0255","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/hh2001.097864","article-title":"Phosphoinositide 3-kinase isoforms selectively couple receptors to vascular L-type Ca (2+) channels","volume":"89","author":"Macrez","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2022.115317_b0260","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-3565(24)37202-7","article-title":"Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine 2A receptor signal transduction","volume":"284","author":"Florian","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeutics"},{"key":"10.1016\/j.bcp.2022.115317_b0265","first-page":"429","article-title":"High glucose levels promote the proliferation of breast cancer cells through GTPases","author":"Hou","year":"2017","journal-title":"Breast Cancer"},{"key":"10.1016\/j.bcp.2022.115317_b0270","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1523-1755.2005.00492.x","article-title":"High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule","volume":"68","author":"Saad","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2022.115317_b0275","doi-asserted-by":"crossref","unstructured":"G. Iaccarino, L.A. Smithwick, R.J. Lefkowitz, W.J. Koch, Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis, Proc. Natl. Acad. Sci. U. S. A., 96 (1999) 3945\u20133950.","DOI":"10.1073\/pnas.96.7.3945"},{"key":"10.1016\/j.bcp.2022.115317_b0280","doi-asserted-by":"crossref","unstructured":"P.E. Marik, J. Iglesias, J. Varon, P. Kory, A scoping review of the pathophysiology of COVID-19, Int. J. Immunopathol. Pharmacol., 35 (2021) 20587384211048026.","DOI":"10.1177\/20587384211048026"},{"key":"10.1016\/j.bcp.2022.115317_b0285","doi-asserted-by":"crossref","unstructured":"T. Guo, Y. Fan, M. Chen, X. Wu, L. Zhang, T. He, H. Wang, J. Wan, X. Wang & Z. Lu, Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19), JAMA Cardiology, 5 (2020) 811\u2013818.","DOI":"10.1001\/jamacardio.2020.1017"},{"key":"10.1016\/j.bcp.2022.115317_b0290","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets Can Associate with SARS-Cov-2 RNA and Are Hyperactivated in COVID-19","volume":"127","author":"Zaid","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2022.115317_b0295","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency","volume":"327","author":"Yu","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2022.115317_b0300","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.102.038083","article-title":"Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases","volume":"303","author":"Quinn","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222004117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:48:19Z","timestamp":1757771299000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222004117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":60,"alternative-id":["S0006295222004117"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115317","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Ca2+\/CaM, Src kinase and\/or PI3K-dependent EGFR transactivation via 5-HT2A and 5-HT1B receptor subtypes mediates 5-HT-induced vasoconstriction","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115317"}}